Will the short duration of Tablet Bicalutamide prevent catheter dependence in patients with urinary retention due to benign prostatic hypertrophy?
Not Applicable
- Conditions
- Health Condition 1: N399- Disorder of urinary system, unspecified
- Registration Number
- CTRI/2023/01/049027
- Lead Sponsor
- SRI BALAJI VIDYAPEETH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ALL PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY WITH REFRACTORY RETENTION, WHO FAIL TRIAL VOID WITHOUT CATHETER ON DUAL DRUG THERAPY
Exclusion Criteria
PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY ON CATHETER OPTING FOR SURGERY.
PATIENTS WITH OTHER UROLOGICAL DISEASES SUCH AS BLADDER CALCULI DUE TO BENIGN PROSTATIC HYPERTROPHY, CHRONIC URINARY RETENTION, RECURRENT URINARY TRACT INFECTION, AND PROSTATIC ADENOCARCINOMA.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO EVALUATE THE RESULTS OF TRIAL VOID WITHOUT CATHETER WITH THREE MONTHS OF BICALUTAMIDE, IN PATIENTS WITH REFRACTORY URINARY RETENTION DUE TO BENIGN PROSTATIC HYPERTROPHY. <br/ ><br> <br/ ><br>INTERNATIONAL PROSTATE SYMPTOM SCORE <br/ ><br>UROFLOWMETRY <br/ ><br>POSTVOID RESIDUE AFTER SUCCESSFUL VOID <br/ ><br>ULTRASOUND ABDOMEN WITH PELVISTimepoint: 1 MONTH, 3 MONTH, 6 MONTH AND 12 MONTH
- Secondary Outcome Measures
Name Time Method IPSS SCORE IMPROVEMENT <br/ ><br>SERUM TESTOSTERONE <br/ ><br>SERUM PSATimepoint: 1 MONTH, 3 MONTH, 6 MONTH AND 12 MONTH